We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+11.98%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.25B
AUM Growth
+$34.5M
Cap. Flow
-$87.4M
Cap. Flow %
-6.99%
Top 10 Hldgs %
45.53%
Holding
136
New
1
Increased
21
Reduced
59
Closed
5

Top Buys

Rank Stock Value
1
INCY icon
Incyte
INCY
+$1.85M
2
CVS icon
CVS Health
CVS
+$228K
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$184K
4
SNPS icon
Synopsys
SNPS
+$29.8K
5
MSFT icon
Microsoft
MSFT
+$28.8K

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$6.32M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$5.86M
3
KLAC icon
KLA
KLAC
+$5.4M
4
LOW icon
Lowe's Companies
LOW
+$4.44M
5
SCHW
Charles Schwab
SCHW
+$4.37M

Sector Composition

Rank Sector Weight
1 Technology 45.76%
2 Healthcare 15.36%
3 Communication Services 14.06%
4 Consumer Discretionary 11.65%
5 Financials 10.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UNH icon
76
UnitedHealth
UNH
$382B
$2M 0.16%
4,169
ABBV icon
77
AbbVie
ABBV
$458B
$2M 0.16%
14,823
JAZZ icon
78
Jazz Pharmaceuticals
JAZZ
$15.9B
$1.87M 0.15%
15,117
+1,370
+10% +$184K
ELV icon
79
Elevance Health
ELV
$81.9B
$1.86M 0.15%
4,182
-5
-0.1% -$2.31K
BIO icon
80
Bio-Rad Laboratories Class A
BIO
$8.42B
$1.85M 0.15%
4,890
JKHY icon
81
Jack Henry & Associates
JKHY
$10.7B
$1.82M 0.15%
10,875
BIIB icon
82
Biogen
BIIB
$29.9B
$1.76M 0.14%
6,190
INCY icon
83
Incyte
INCY
$23.5B
$1.72M 0.14%
+27,651
New +$1.85M
SAIC icon
84
Saic
SAIC
$5.03B
$1.68M 0.13%
14,972
SYK icon
85
Stryker
SYK
$127B
$1.67M 0.13%
5,482
HUM icon
86
Humana
HUM
$46.7B
$1.67M 0.13%
3,730
MOH icon
87
Molina Healthcare
MOH
$10.3B
$1.66M 0.13%
5,495
MRNA icon
88
Moderna
MRNA
$21.5B
$1.59M 0.13%
13,081
FTNT icon
89
Fortinet
FTNT
$112B
$1.57M 0.13%
20,800
CTRA
90
DELISTED
Coterra Energy
CTRA
$1.56M 0.12%
61,541
FFIV icon
91
F5
FFIV
$22.1B
$1.54M 0.12%
10,525
TSLA icon
92
Tesla
TSLA
$1.24T
$1.52M 0.12%
5,817
ILMN icon
93
Illumina
ILMN
$29.4B
$1.5M 0.12%
8,249
-586
-7% -$119K
JNJ icon
94
Johnson & Johnson
JNJ
$635B
$1.41M 0.11%
8,539
-800
-9% -$129K
CNC icon
95
Centene
CNC
$31.3B
$1.34M 0.11%
19,900
PCTY icon
96
Paylocity
PCTY
$6.71B
$1.33M 0.11%
7,220
CVS icon
97
CVS Health
CVS
$137B
$1.26M 0.1%
18,200
+3,200
+21% +$228K
IBM icon
98
IBM
IBM
$202B
$1.11M 0.09%
8,261
-14,007
-63% -$1.81M
KAI icon
99
Kadant
KAI
$3.69B
$1.04M 0.08%
4,668
VRNT
100
DELISTED
Verint Systems
VRNT
$941K 0.08%
26,833
-6,160
-19% -$222K

Similar funds

Oak Associates's Q2 2023 Portfolio in Review

As of Q2 2023, Oak Associates held 136 positions worth $1.25B, up 2.8% from $1.22B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Oak Associates withdrew a net $87.4M in Q2 2023, closing 5 positions and reducing 59 holdings. Its most notable exit was Ubiquiti, an estimated $1.54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 46% of assets, up from 45% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Oak Associates opened a new position in Incyte worth $1.72M.

  • Oak Associates's largest Q2 2023 buy was Incyte: 27,651 shares worth $1.72M.
  • Oak Associates added most to CVS Health in Q2 2023, an estimated $228K increase.
  • Oak Associates's biggest Q2 2023 reduction was Amazon, cutting an estimated $6.32M.
  • Oak Associates fully exited Ubiquiti in Q2 2023, selling an estimated $1.54M.
  • Oak Associates's ten largest holdings make up 46% of its $1.25B portfolio in Q2 2023.
  • Oak Associates opened 1 new position and closed 5 in Q2 2023.
  • Oak Associates's portfolio value rose 2.8% quarter-over-quarter to $1.25B.

Based on Oak Associates's 13F filing for Q2 2023, filed 11 Aug 2023.